The researchers hope the datasets from their study can help to explain the effects of disease-associated variants on specific cell types of the immune system.
HuBMAP is not anticipated to map the entire body, but to provide a framework for more complete mapping and make data available to the research community.
ACEA's xCELLigence impedance-based, label-free, real-time cell analysis instruments are used in immuno-oncology pre-clinical drug discovery and development.
By sequencing 72,501 individual kidney cells, researchers saw some shared transcriptional patterns in kidney cancers and developing or adult kidneys.
Researchers integrated results from a pathogen-host association study with available clinical data to find variants influencing both infection responses and other disease risks.
Researchers have found genomic, transcriptomic, proteomic, and phenotypic variation in a comparison of HeLa cells across laboratories and over time.
Ireland-based Luxcel is a developer of real-time fluorescence plate reader-based in vitro cell assay kits.
The grant is being provided under the European Commission's Horizon 2020 Research and Innovation Framework program.
Harvard Bioscience will offer Fluxion's BioFlux and IonFlux cellular analysis platforms to its North American customers.
CEO Anders Rylander said the company will initially market its DiviTum assay for breast cancer cases, though it could be used to monitor cell proliferation in all cancer types.
The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.
A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.
Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.
In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.